These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 25761889)

  • 1. Scanning ultrasound removes amyloid-β and restores memory in an Alzheimer's disease mouse model.
    Leinenga G; Götz J
    Sci Transl Med; 2015 Mar; 7(278):278ra33. PubMed ID: 25761889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous infusion of monocytes isolated from 2-week-old mice enhances clearance of Beta-amyloid plaques in an Alzheimer mouse model.
    Hohsfield LA; Humpel C
    PLoS One; 2015; 10(4):e0121930. PubMed ID: 25830951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal changes of CD68 and α7 nicotinic acetylcholine receptor expression in microglia in Alzheimer's disease-like mouse models.
    Matsumura A; Suzuki S; Iwahara N; Hisahara S; Kawamata J; Suzuki H; Yamauchi A; Takata K; Kitamura Y; Shimohama S
    J Alzheimers Dis; 2015; 44(2):409-23. PubMed ID: 25352454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
    Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
    Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of the effects of Aducanumab and scanning ultrasound on amyloid plaques and behavior in the APP23 mouse model of Alzheimer disease.
    Leinenga G; Koh WK; Götz J
    Alzheimers Res Ther; 2021 Apr; 13(1):76. PubMed ID: 33836798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic Toxoplasma gondii infection enhances β-amyloid phagocytosis and clearance by recruited monocytes.
    Möhle L; Israel N; Paarmann K; Krohn M; Pietkiewicz S; Müller A; Lavrik IN; Buguliskis JS; Schott BH; Schlüter D; Gundelfinger ED; Montag D; Seifert U; Pahnke J; Dunay IR
    Acta Neuropathol Commun; 2016 Mar; 4():25. PubMed ID: 26984535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stromal cell-derived factor 1α decreases β-amyloid deposition in Alzheimer's disease mouse model.
    Wang Q; Xu Y; Chen JC; Qin YY; Liu M; Liu Y; Xie MJ; Yu ZY; Zhu Z; Wang W
    Brain Res; 2012 Jun; 1459():15-26. PubMed ID: 22560596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
    Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
    Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid-β plaque reduction, endogenous antibody delivery and glial activation by brain-targeted, transcranial focused ultrasound.
    Jordão JF; Thévenot E; Markham-Coultes K; Scarcelli T; Weng YQ; Xhima K; O'Reilly M; Huang Y; McLaurin J; Hynynen K; Aubert I
    Exp Neurol; 2013 Oct; 248():16-29. PubMed ID: 23707300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impacts of aging and amyloid-β deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer's disease.
    Bi Oh S; Suh N; Kim I; Lee JY
    Brain Res; 2015 Feb; 1597():159-67. PubMed ID: 25454795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined treatment of amyloid-β₁₋₄₂-stimulated bone marrow-derived dendritic cells plus splenocytes from young mice prevents the development of Alzheimer's disease in APPswe/PSENldE9 mice.
    Wang F; Liu H; Shen X; Ao H; Moore N; Gao L; Chen L; Hu H; Ma H; Yang Z; Zhai C; Qin J; Zhou G; Peng Y; Feng X; Li R; Liang C
    Neurobiol Aging; 2015 Jan; 36(1):111-22. PubMed ID: 25085784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of CRFR1 Ablation on Amyloid-β Production and Accumulation in a Mouse Model of Alzheimer's Disease.
    Campbell SN; Zhang C; Roe AD; Lee N; Lao KU; Monte L; Donohue MC; Rissman RA
    J Alzheimers Dis; 2015; 45(4):1175-84. PubMed ID: 25697705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amelioration of amyloid-β-induced deficits by DcR3 in an Alzheimer's disease model.
    Liu YL; Chen WT; Lin YY; Lu PH; Hsieh SL; Cheng IH
    Mol Neurodegener; 2017 Apr; 12(1):30. PubMed ID: 28438208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct inflammatory phenotypes of microglia and monocyte-derived macrophages in Alzheimer's disease models: effects of aging and amyloid pathology.
    Martin E; Boucher C; Fontaine B; Delarasse C
    Aging Cell; 2017 Feb; 16(1):27-38. PubMed ID: 27723233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of microglial activation in a mouse model of Alzheimer's disease via NFAT inhibition.
    Rojanathammanee L; Floden AM; Manocha GD; Combs CK
    J Neuroinflammation; 2015 Mar; 12():42. PubMed ID: 25889879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progranulin protects against amyloid β deposition and toxicity in Alzheimer's disease mouse models.
    Minami SS; Min SW; Krabbe G; Wang C; Zhou Y; Asgarov R; Li Y; Martens LH; Elia LP; Ward ME; Mucke L; Farese RV; Gan L
    Nat Med; 2014 Oct; 20(10):1157-64. PubMed ID: 25261995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cooperative therapeutic action of retinoic acid receptor and retinoid x receptor agonists in a mouse model of Alzheimer's disease.
    Kawahara K; Suenobu M; Ohtsuka H; Kuniyasu A; Sugimoto Y; Nakagomi M; Fukasawa H; Shudo K; Nakayama H
    J Alzheimers Dis; 2014; 42(2):587-605. PubMed ID: 24916544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scanning ultrasound in the absence of blood-brain barrier opening is not sufficient to clear β-amyloid plaques in the APP23 mouse model of Alzheimer's disease.
    Leinenga G; Koh WK; Götz J
    Brain Res Bull; 2019 Nov; 153():8-14. PubMed ID: 31400496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo SPECT imaging of amyloid-β deposition with radioiodinated imidazo[1,2-a]pyridine derivative DRM106 in a mouse model of Alzheimer's disease.
    Chen CJ; Bando K; Ashino H; Taguchi K; Shiraishi H; Shima K; Fujimoto O; Kitamura C; Matsushima S; Uchida K; Nakahara Y; Kasahara H; Minamizawa T; Jiang C; Zhang MR; Ono M; Tokunaga M; Suhara T; Higuchi M; Yamada K; Ji B
    J Nucl Med; 2015 Jan; 56(1):120-6. PubMed ID: 25476539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies targeted to the brain with image-guided focused ultrasound reduces amyloid-beta plaque load in the TgCRND8 mouse model of Alzheimer's disease.
    Jordão JF; Ayala-Grosso CA; Markham K; Huang Y; Chopra R; McLaurin J; Hynynen K; Aubert I
    PLoS One; 2010 May; 5(5):e10549. PubMed ID: 20485502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.